De novo Absence Status Epilepticus in a pediatric cohort: Electroclinical pattern in a multicenter Italian patients

C Pepi1, E Cesaroni2, P Striano3

  • 1Child Neurology Unit, Department of Neuroscience and Neurorehabilitation, Bambino Gesù Children's Hospital Research Institute, Rome, Italy; Child Neurology and Psychiatry Unit, System Medicine Unit, Tor Vergata University, Rome, Italy.

Seizure
|November 29, 2019
PubMed

Insights

Absence Status Epilepticus (AS) in children can be a distinct epilepsy syndrome. Early antiepileptic drug treatment is crucial to prevent recurrent seizures and ensure a good prognosis.

Area of Science:

  • Neurology
  • Pediatric Epilepsy
  • Genetics

Background:

  • Absence Status Epilepticus (AS) is a prolonged, generalized, non-convulsive seizure affecting consciousness.
  • It can be the sole manifestation of epilepsy in children with normal development.

Purpose of the Study:

  • To describe pediatric patients with recurrent, unprovoked de novo AS.
  • To evaluate the response to antiepileptic drugs (AEDs) in these patients.

Main Methods:

  • Retrospective review of 13 pediatric patients (2005-2019).
  • Inclusion criteria: normal development, AS as only manifestation, normal tests, EEG, and follow-up.
  • Genetic testing (aCGH, karyotype, NGS, WES) performed in 10 patients.

Main Results:

  • 13 patients (7 female, 6 male), mean age at onset 9.3 years.
  • Excellent response to Valproic Acid (VPA) or Ethosuximide (ETS).
  • 5 patients with delayed treatment experienced recurrent AS; 10 underwent genetic testing.

Conclusions:

  • De novo AS may represent a distinct, age-related, self-limited epilepsy syndrome.
  • Prognosis is good with AEDs, but relapse risk is high if untreated.
  • Early and adequate AED therapy is essential.
Abstract